GKB Ophthalmics Ltd is in the business of manufacture and sale of ophthalmic lenses made up of Glass and PlasticProduct Profile: a) Single Vision: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck 1.56 DayNite, 1.56 DayNite FAST CHANGE, 1.50 Q-SHADE +, 1.50 SunSensor b) Bifocal: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck, 1.56...
GKB Ophthalmics has completed dispatch of its 2024-25 Annual Report and Notice for the 43rd Annual General Meeting (AGM). The AGM will be held on October 21, 2025, via video conferencing, in compliance with regulatory norms. Shareholders have received the report electronically, with physical copies dispatched to those without registered...
GKB Ophthalmics reported significantly increased net losses for FY25: ₹6.11 Cr standalone and ₹7.08 Cr consolidated, despite revenue growth. Key financial ratios like Return on Networth and Debt-Equity worsened. The company is focused on plastic lenses, investing in new machinery for export orders, and seeking a ₹7.50 Cr term loan...
GKB Ophthalmics Ltd. has released newspaper notices regarding its upcoming Annual General Meeting (AGM). These notices were published in The Times of India and Pudhari. This update signifies the company's preparation for its important annual shareholder gathering, where crucial company affairs are addressed. It ensures shareholders are duly informed about...
GKB Ophthalmics Ltd has announced a certificate confirming that all securities received for dematerialisation during the quarter ended June 30, 2025, were processed and confirmed by the registrar. The securities have been listed on the stock exchanges where existing shares are traded. Security certificates received were verified, mutilated, and cancelled,...
Krishna Gopal Gupta & Sons (HUF), part of GKB Ophthalmics’ promoter group, has acquired 3,535 equity shares worth Rs. 2.7 lakh on the market between June 12 and June 23, 2025. The entity has committed to holding these shares for at least six months, seeking prior approval if a sale...
